Interleukin-23 as a therapeutic target for inflammatory myopathy

Current treatments of polymyositis and dermatomyositis (PM/DM) depend on non-specific immunosuppressants. This study was performed to elucidate the role of interleukin (IL)-23, as their possible therapeutic target. As was reported earlier in PM/DM patients, serum IL-23 levels were elevated in mice w...

Descripción completa

Detalles Bibliográficos
Autores principales: Umezawa, Natsuka, Kawahata, Kimito, Mizoguchi, Fumitaka, Kimura, Naoki, Yoshihashi-Nakazato, Yoko, Miyasaka, Nobuyuki, Kohsaka, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882883/
https://www.ncbi.nlm.nih.gov/pubmed/29615652
http://dx.doi.org/10.1038/s41598-018-23539-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882883/
https://www.ncbi.nlm.nih.gov/pubmed/29615652
http://dx.doi.org/10.1038/s41598-018-23539-4

Ejemplares similares